Cell Culture Technology– category –
-
Scaling Animal-Free Proteins from Precision Fermentation Faces Challenges: Cost and Process Control Barriers from Lab to Market
MDPI Switzerland Overview Scaling animal-free proteins produced via precision fermentation from lab to industrial production faces significant challenges, including maintaining strain performance, high media costs, and precise bioprocess... -
Reinventing CAR T-Cell Access: How Localized Manufacturing in Turkey and China is Driving Down Costs
Bookimed Turkey Overview The prohibitively high cost of CAR T-cell therapy severely limits patient access worldwide, with prices fluctuating significantly based on manufacturing and treatment location. However, localized production, nota... -
Allogeneic CAR-T Manufacturing: Unlocking Rapid, Off-the-Shelf Cancer Therapy
Liv Hospital Turkey Overview Allogeneic CAR-T cell manufacturing is poised to revolutionize cancer treatment by providing 'off-the-shelf' solutions derived from healthy donor cells. This approach dramatically shortens treatment timelines... -
Precision Fermentation Emerges as Transformative Food Production Technology, Enabling Scalable and Cost-Effective Alternative Ingredient Supply
KLBD Kosher Certification UK Overview Precision fermentation is rapidly gaining recognition as an innovative technology in food production, enabling the scalable and cost-effective manufacturing of diverse ingredients, including those ch... -
Thermo Fisher Scientific Unveils Semi-Automated, Closed-Loop Workflow for Autologous CAR T Cell Manufacturing: A Leap in Consistency and Safety
Thermo Fisher Scientific USA Overview Thermo Fisher Scientific has introduced a new digitally compatible, semi-automated, closed, and GMP-compliant workflow platform designed to streamline autologous CAR T cell manufacturing. Integrating... -
Beckman Coulter Showcases BioLector XT Micro Bioreactor and Biomek i5 Automated Liquid Handler to Accelerate Precision Fermentation and Alternative Protein Research
Beckman Coulter Life Sciences (YouTube) USA Overview Chris Saenz of Beckman Coulter Life Sciences introduced key technologies accelerating early-stage microbiology engineering for precision fermentation and alternative proteins. The BioL... -
Methodist Healthcare Expands CAR T-Cell Therapy Trials Beyond Cancer to Autoimmune Diseases like Lupus and MS, Including Pediatric Patients
San Antonio Report USA Overview Methodist Healthcare is expanding CAR T-cell therapy clinical trials beyond oncology, actively researching applications for autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and Multiple Scler... -
ProBio Opens $25 Million Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, Creating Over 100 Highly Skilled Jobs
New Jersey Business Magazine USA Overview ProBio has inaugurated a $25 million, 128,000-square-foot Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, significantly bolstering its production capabilities for cell an... -
Precision Fermentation Powers All G’s Industrial-Scale Launch of Animal-Free Lactoferrin ‘LFX Apoprotein’ in US Market
AgFunderNews Australia Overview Australian biotechnology firm All G has commercially launched LFX Apoprotein, a novel animal-free, low-iron lactoferrin produced via precision fermentation, in the U.S. market. Currently scaled at a 60,000... -
FDA Approves Orca Bio’s Precision-Engineered Cell Therapy Tregzi (Orca-T) for Allogeneic Transplant in Adults with Hematological Malignancies
CliniExpert USA Overview The U.S. FDA has approved Orca Bio’s precision-engineered cell therapy, Tregzi™ (Orca-T®), for allogeneic transplant in adult patients with hematological malignancies. Tregzi is a personalized therapy manufacture...
